Company News
HSA grants PSAR for Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal
Date | 2022.03.05 | Hit | 2200 | ||
---|---|---|---|---|---|
As
of 23 February 2022, Singapore Health Sciences Authority (HSA) has authorized BIOCREDIT
COVID-19 OTC self-test kits for use in Singapore. Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal kits will be available in stores from March amid Singapore logging a record high of 18,162 new Covid-19 cases on March 3, a total of 785,825 accumulated cases thus far.
For
self-tests that have been authorized by HSA under PSAR, please visit : https://www.hsa.gov.sg/consumer-safety/articles/covid19_selftests
(*PSAR : Pandemic Special Access Route) |